BIO-Europe Spring® 2016: Strategic unit at MD Anderson forges creative alliances

June 22, 2016
Shara Avis, business development specialist at MD Anderson Cancer Center—a world-renown research center—speaks to Mike Ward, global director of content for Informa Pharma Intelligence's insights portfolio, about how the center's strategic industry ventures unit is connecting companies with the research facility in a new way. During the BIO-Europe Spring partnering conference in Stockholm, Sweden, they discuss what the strategic industry unit has achieved so far and how it is targeting creative alliances to advance cancer therapies.
Previous Article
Hey big spender: Top paid CEOs ready to splash the cash
Hey big spender: Top paid CEOs ready to splash the cash

It’s an interesting facet of the Top 10 highest-paid CEOs that only three of them are leading a Top 10 phar...

Next Video
BIO-Europe Spring® 2016: How to get Takeda Ventures to notice your startup
BIO-Europe Spring® 2016: How to get Takeda Ventures to notice your startup

Dr. Ilan Zipkin, senior investment director at Takeda Ventures, talks with Mike Ward, global director of co...